AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies

Name: Work Video:
Duration: 3 min 30 s
Sonya Zabludoff; Chun Deng; Michael Grondine; Adam Sheehy; Susan Ashwell; Benjamin Caleb; Stephen Green; Heather Haye; Candice L. Horn; James W. Janetka; Dongfang Liu; Elizabeth Mouchet; Shannon Ready; Judith L. Rosenthal; Christophe Quéva; Gary K. Schwartz; Karen J. Taylor; Archie Tse; Graeme E. Walker; Anne M. White
{'id': 'https://openalex.org/W2162730779', 'doi': 'https://doi.org/10.1158/1535-7163.mct-08-0492', 'title': 'AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies', 'display_name': 'AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies', 'publication_year': 2008, 'publication_date': '2008-09-01', 'ids': {'openalex': 'https://openalex.org/W2162730779', 'doi': 'https://doi.org/10.1158/1535-7163.mct-08-0492', 'mag': '2162730779', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/18790776'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.mct-08-0492', 'pdf_url': 'https://mct.aacrjournals.org/content/molcanther/7/9/2955.full.pdf', 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://mct.aacrjournals.org/content/molcanther/7/9/2955.full.pdf', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5111904185', 'display_name': 'Sonya Zabludoff', 'orcid': 'https://orcid.org/0000-0003-1786-6241'}, 'institutions': [{'id': 'https://openalex.org/I4210150756', 'display_name': 'AstraZeneca (United States)', 'ror': 'https://ror.org/043cec594', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I105036370', 'https://openalex.org/I4210150756']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Sonya D. Zabludoff', 'raw_affiliation_strings': ['1AstraZeneca R&D Boston, Waltham, Massachusetts;'], 'affiliations': [{'raw_affiliation_string': '1AstraZeneca R&D Boston, Waltham, Massachusetts;', 'institution_ids': ['https://openalex.org/I4210150756']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103184577', 'display_name': 'Chun Deng', 'orcid': 'https://orcid.org/0009-0001-8611-0416'}, 'institutions': [{'id': 'https://openalex.org/I4210150756', 'display_name': 'AstraZeneca (United States)', 'ror': 'https://ror.org/043cec594', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I105036370', 'https://openalex.org/I4210150756']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Chun Deng', 'raw_affiliation_strings': ['1AstraZeneca R&D Boston, Waltham, Massachusetts;'], 'affiliations': [{'raw_affiliation_string': '1AstraZeneca R&D Boston, Waltham, Massachusetts;', 'institution_ids': ['https://openalex.org/I4210150756']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5049708947', 'display_name': 'Michael Grondine', 'orcid': 'https://orcid.org/0000-0001-7806-1864'}, 'institutions': [{'id': 'https://openalex.org/I4210150756', 'display_name': 'AstraZeneca (United States)', 'ror': 'https://ror.org/043cec594', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I105036370', 'https://openalex.org/I4210150756']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Michael R. Grondine', 'raw_affiliation_strings': ['1AstraZeneca R&D Boston, Waltham, Massachusetts;'], 'affiliations': [{'raw_affiliation_string': '1AstraZeneca R&D Boston, Waltham, Massachusetts;', 'institution_ids': ['https://openalex.org/I4210150756']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5045342674', 'display_name': 'Adam Sheehy', 'orcid': 'https://orcid.org/0000-0003-0080-8950'}, 'institutions': [{'id': 'https://openalex.org/I4210150756', 'display_name': 'AstraZeneca (United States)', 'ror': 'https://ror.org/043cec594', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I105036370', 'https://openalex.org/I4210150756']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Adam M. Sheehy', 'raw_affiliation_strings': ['1AstraZeneca R&D Boston, Waltham, Massachusetts;'], 'affiliations': [{'raw_affiliation_string': '1AstraZeneca R&D Boston, Waltham, Massachusetts;', 'institution_ids': ['https://openalex.org/I4210150756']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5108554420', 'display_name': 'Susan Ashwell', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210150756', 'display_name': 'AstraZeneca (United States)', 'ror': 'https://ror.org/043cec594', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I105036370', 'https://openalex.org/I4210150756']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Susan Ashwell', 'raw_affiliation_strings': ['1AstraZeneca R&D Boston, Waltham, Massachusetts;'], 'affiliations': [{'raw_affiliation_string': '1AstraZeneca R&D Boston, Waltham, Massachusetts;', 'institution_ids': ['https://openalex.org/I4210150756']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5078911329', 'display_name': 'Benjamin Caleb', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210150756', 'display_name': 'AstraZeneca (United States)', 'ror': 'https://ror.org/043cec594', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I105036370', 'https://openalex.org/I4210150756']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Benjamin L. Caleb', 'raw_affiliation_strings': ['1AstraZeneca R&D Boston, Waltham, Massachusetts;'], 'affiliations': [{'raw_affiliation_string': '1AstraZeneca R&D Boston, Waltham, Massachusetts;', 'institution_ids': ['https://openalex.org/I4210150756']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101922667', 'display_name': 'Stephen Green', 'orcid': 'https://orcid.org/0009-0000-5382-7974'}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Stephen Green', 'raw_affiliation_strings': ['2AstraZeneca, Cheshire, United Kingdom; and'], 'affiliations': [{'raw_affiliation_string': '2AstraZeneca, Cheshire, United Kingdom; and', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5044579265', 'display_name': 'Heather Haye', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Heather R. Haye', 'raw_affiliation_strings': ['2AstraZeneca, Cheshire, United Kingdom; and'], 'affiliations': [{'raw_affiliation_string': '2AstraZeneca, Cheshire, United Kingdom; and', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5090689034', 'display_name': 'Candice L. Horn', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210150756', 'display_name': 'AstraZeneca (United States)', 'ror': 'https://ror.org/043cec594', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I105036370', 'https://openalex.org/I4210150756']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Candice L. Horn', 'raw_affiliation_strings': ['1AstraZeneca R&D Boston, Waltham, Massachusetts;'], 'affiliations': [{'raw_affiliation_string': '1AstraZeneca R&D Boston, Waltham, Massachusetts;', 'institution_ids': ['https://openalex.org/I4210150756']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5049539326', 'display_name': 'James W. Janetka', 'orcid': 'https://orcid.org/0000-0002-9888-5411'}, 'institutions': [{'id': 'https://openalex.org/I4210150756', 'display_name': 'AstraZeneca (United States)', 'ror': 'https://ror.org/043cec594', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I105036370', 'https://openalex.org/I4210150756']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'James W. Janetka', 'raw_affiliation_strings': ['1AstraZeneca R&D Boston, Waltham, Massachusetts;'], 'affiliations': [{'raw_affiliation_string': '1AstraZeneca R&D Boston, Waltham, Massachusetts;', 'institution_ids': ['https://openalex.org/I4210150756']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5084853102', 'display_name': 'Dongfang Liu', 'orcid': 'https://orcid.org/0000-0002-8801-2190'}, 'institutions': [{'id': 'https://openalex.org/I4210150756', 'display_name': 'AstraZeneca (United States)', 'ror': 'https://ror.org/043cec594', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I105036370', 'https://openalex.org/I4210150756']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Dongfang Liu', 'raw_affiliation_strings': ['1AstraZeneca R&D Boston, Waltham, Massachusetts;'], 'affiliations': [{'raw_affiliation_string': '1AstraZeneca R&D Boston, Waltham, Massachusetts;', 'institution_ids': ['https://openalex.org/I4210150756']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5011030371', 'display_name': 'Elizabeth Mouchet', 'orcid': 'https://orcid.org/0000-0003-3157-9388'}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Elizabeth Mouchet', 'raw_affiliation_strings': ['2AstraZeneca, Cheshire, United Kingdom; and'], 'affiliations': [{'raw_affiliation_string': '2AstraZeneca, Cheshire, United Kingdom; and', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5000162965', 'display_name': 'Shannon Ready', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210150756', 'display_name': 'AstraZeneca (United States)', 'ror': 'https://ror.org/043cec594', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I105036370', 'https://openalex.org/I4210150756']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Shannon Ready', 'raw_affiliation_strings': ['1AstraZeneca R&D Boston, Waltham, Massachusetts;'], 'affiliations': [{'raw_affiliation_string': '1AstraZeneca R&D Boston, Waltham, Massachusetts;', 'institution_ids': ['https://openalex.org/I4210150756']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5006064139', 'display_name': 'Judith L. Rosenthal', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210150756', 'display_name': 'AstraZeneca (United States)', 'ror': 'https://ror.org/043cec594', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I105036370', 'https://openalex.org/I4210150756']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Judith L. Rosenthal', 'raw_affiliation_strings': ['1AstraZeneca R&D Boston, Waltham, Massachusetts;'], 'affiliations': [{'raw_affiliation_string': '1AstraZeneca R&D Boston, Waltham, Massachusetts;', 'institution_ids': ['https://openalex.org/I4210150756']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5067308803', 'display_name': 'Christophe Quéva', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210150756', 'display_name': 'AstraZeneca (United States)', 'ror': 'https://ror.org/043cec594', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I105036370', 'https://openalex.org/I4210150756']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Christophe Queva', 'raw_affiliation_strings': ['1AstraZeneca R&D Boston, Waltham, Massachusetts;'], 'affiliations': [{'raw_affiliation_string': '1AstraZeneca R&D Boston, Waltham, Massachusetts;', 'institution_ids': ['https://openalex.org/I4210150756']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5006913373', 'display_name': 'Gary K. Schwartz', 'orcid': 'https://orcid.org/0000-0003-1813-5061'}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Gary K. Schwartz', 'raw_affiliation_strings': ['3Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York'], 'affiliations': [{'raw_affiliation_string': '3Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York', 'institution_ids': ['https://openalex.org/I1334819555']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5077035638', 'display_name': 'Karen J. Taylor', 'orcid': 'https://orcid.org/0000-0002-2265-5097'}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Karen J. Taylor', 'raw_affiliation_strings': ['2AstraZeneca, Cheshire, United Kingdom; and'], 'affiliations': [{'raw_affiliation_string': '2AstraZeneca, Cheshire, United Kingdom; and', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5114045976', 'display_name': 'Archie Tse', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Archie N. Tse', 'raw_affiliation_strings': ['3Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York'], 'affiliations': [{'raw_affiliation_string': '3Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York', 'institution_ids': ['https://openalex.org/I1334819555']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5061486623', 'display_name': 'Graeme E. Walker', 'orcid': 'https://orcid.org/0000-0001-5344-9942'}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Graeme E. Walker', 'raw_affiliation_strings': ['2AstraZeneca, Cheshire, United Kingdom; and'], 'affiliations': [{'raw_affiliation_string': '2AstraZeneca, Cheshire, United Kingdom; and', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5085361893', 'display_name': 'Anne M. White', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Anne M. White', 'raw_affiliation_strings': ['2AstraZeneca, Cheshire, United Kingdom; and'], 'affiliations': [{'raw_affiliation_string': '2AstraZeneca, Cheshire, United Kingdom; and', 'institution_ids': ['https://openalex.org/I105036370']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 3, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 11.954, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 396, 'citation_normalized_percentile': {'value': 0.999983, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 99, 'max': 100}, 'biblio': {'volume': '7', 'issue': '9', 'first_page': '2955', 'last_page': '2966'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10123', 'display_name': 'DNA Repair Mechanisms', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10123', 'display_name': 'DNA Repair Mechanisms', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11845', 'display_name': 'Cancer therapeutics and mechanisms', 'score': 0.9995, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10492', 'display_name': 'Microtubule and mitosis dynamics', 'score': 0.9991, 'subfield': {'id': 'https://openalex.org/subfields/1307', 'display_name': 'Cell Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/chek1', 'display_name': 'CHEK1', 'score': 0.9077188}, {'id': 'https://openalex.org/keywords/checkpoint-kinase-2', 'display_name': 'Checkpoint Kinase 2', 'score': 0.6931469}], 'concepts': [{'id': 'https://openalex.org/C50001416', 'wikidata': 'https://www.wikidata.org/wiki/Q17861750', 'display_name': 'CHEK1', 'level': 5, 'score': 0.9077188}, {'id': 'https://openalex.org/C54086632', 'wikidata': 'https://www.wikidata.org/wiki/Q5512671', 'display_name': 'G2-M DNA damage checkpoint', 'level': 5, 'score': 0.7858355}, {'id': 'https://openalex.org/C143425029', 'wikidata': 'https://www.wikidata.org/wiki/Q5205747', 'display_name': 'DNA damage', 'level': 3, 'score': 0.72111917}, {'id': 'https://openalex.org/C2910325170', 'wikidata': 'https://www.wikidata.org/wiki/Q14912280', 'display_name': 'Checkpoint Kinase 2', 'level': 5, 'score': 0.6931469}, {'id': 'https://openalex.org/C105696609', 'wikidata': 'https://www.wikidata.org/wiki/Q1068809', 'display_name': 'Cell cycle checkpoint', 'level': 4, 'score': 0.6626018}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.61558735}, {'id': 'https://openalex.org/C134935766', 'wikidata': 'https://www.wikidata.org/wiki/Q210538', 'display_name': 'DNA repair', 'level': 3, 'score': 0.60710007}, {'id': 'https://openalex.org/C184235292', 'wikidata': 'https://www.wikidata.org/wiki/Q421851', 'display_name': 'Kinase', 'level': 2, 'score': 0.48153955}, {'id': 'https://openalex.org/C29537977', 'wikidata': 'https://www.wikidata.org/wiki/Q188941', 'display_name': 'Cell cycle', 'level': 3, 'score': 0.4738208}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.40315098}, {'id': 'https://openalex.org/C95444343', 'wikidata': 'https://www.wikidata.org/wiki/Q7141', 'display_name': 'Cell biology', 'level': 1, 'score': 0.37044445}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.27416593}, {'id': 'https://openalex.org/C552990157', 'wikidata': 'https://www.wikidata.org/wiki/Q7430', 'display_name': 'DNA', 'level': 2, 'score': 0.16908461}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.08809605}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.06727162}], 'mesh': [{'descriptor_ui': 'D004249', 'descriptor_name': 'DNA Damage', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D004273', 'descriptor_name': 'DNA, Neoplasm', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D011494', 'descriptor_name': 'Protein Kinases', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D013876', 'descriptor_name': 'Thiophenes', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D014508', 'descriptor_name': 'Urea', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001681', 'descriptor_name': 'Biological Assay', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018797', 'descriptor_name': 'Cell Cycle Proteins', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D018797', 'descriptor_name': 'Cell Cycle Proteins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016923', 'descriptor_name': 'Cell Death', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D016923', 'descriptor_name': 'Cell Death', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000071877', 'descriptor_name': 'Checkpoint Kinase 1', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004273', 'descriptor_name': 'DNA, Neoplasm', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003841', 'descriptor_name': 'Deoxycytidine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003841', 'descriptor_name': 'Deoxycytidine', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D003841', 'descriptor_name': 'Deoxycytidine', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': False}, {'descriptor_ui': 'D004357', 'descriptor_name': 'Drug Synergism', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016195', 'descriptor_name': 'G2 Phase', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D016195', 'descriptor_name': 'G2 Phase', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D045325', 'descriptor_name': 'HCT116 Cells', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019073', 'descriptor_name': 'HT29 Cells', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051379', 'descriptor_name': 'Mice', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009154', 'descriptor_name': 'Mutation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009154', 'descriptor_name': 'Mutation', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': 'Q000032', 'qualifier_name': 'analysis', 'is_major_topic': False}, {'descriptor_ui': 'D011494', 'descriptor_name': 'Protein Kinases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051381', 'descriptor_name': 'Rats', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013876', 'descriptor_name': 'Thiophenes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013876', 'descriptor_name': 'Thiophenes', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D013876', 'descriptor_name': 'Thiophenes', 'qualifier_ui': 'Q000032', 'qualifier_name': 'analysis', 'is_major_topic': False}, {'descriptor_ui': 'D019772', 'descriptor_name': 'Topotecan', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019772', 'descriptor_name': 'Topotecan', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D016159', 'descriptor_name': 'Tumor Suppressor Protein p53', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D016159', 'descriptor_name': 'Tumor Suppressor Protein p53', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014508', 'descriptor_name': 'Urea', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D014508', 'descriptor_name': 'Urea', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D014508', 'descriptor_name': 'Urea', 'qualifier_ui': 'Q000032', 'qualifier_name': 'analysis', 'is_major_topic': False}, {'descriptor_ui': 'D014508', 'descriptor_name': 'Urea', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D023041', 'descriptor_name': 'Xenograft Model Antitumor Assays', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 3, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.mct-08-0492', 'pdf_url': 'https://mct.aacrjournals.org/content/molcanther/7/9/2955.full.pdf', 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.22485723', 'pdf_url': 'https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_from_AZD7762_a_novel_checkpoint_kinase_inhibitor_drives_checkpoint_abrogation_and_potentiates_DNA-targeted_therapies/22485723/1/files/39937284.pdf', 'source': None, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'submittedVersion', 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/18790776', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.mct-08-0492', 'pdf_url': 'https://mct.aacrjournals.org/content/molcanther/7/9/2955.full.pdf', 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.81, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 38, 'referenced_works': ['https://openalex.org/W1837329986', 'https://openalex.org/W1969355167', 'https://openalex.org/W1972185917', 'https://openalex.org/W1975813162', 'https://openalex.org/W1979986967', 'https://openalex.org/W1996505651', 'https://openalex.org/W2002696717', 'https://openalex.org/W2035834282', 'https://openalex.org/W2045436471', 'https://openalex.org/W2049877855', 'https://openalex.org/W2071088216', 'https://openalex.org/W2075707444', 'https://openalex.org/W2076314401', 'https://openalex.org/W2082140471', 'https://openalex.org/W2083225541', 'https://openalex.org/W2097173890', 'https://openalex.org/W2105592350', 'https://openalex.org/W2105768236', 'https://openalex.org/W2110698289', 'https://openalex.org/W2116052046', 'https://openalex.org/W2116372610', 'https://openalex.org/W2126583326', 'https://openalex.org/W2130603065', 'https://openalex.org/W2132254460', 'https://openalex.org/W2145339037', 'https://openalex.org/W2146614359', 'https://openalex.org/W2153574313', 'https://openalex.org/W2153812820', 'https://openalex.org/W2158648773', 'https://openalex.org/W2169365607', 'https://openalex.org/W2171806736', 'https://openalex.org/W2316582027', 'https://openalex.org/W2319461533', 'https://openalex.org/W2322339599', 'https://openalex.org/W2412852597', 'https://openalex.org/W2431728799', 'https://openalex.org/W2434105553', 'https://openalex.org/W2565820221'], 'related_works': ['https://openalex.org/W3131888322', 'https://openalex.org/W2528137095', 'https://openalex.org/W2225210933', 'https://openalex.org/W2147331022', 'https://openalex.org/W2118629005', 'https://openalex.org/W2039775251', 'https://openalex.org/W2019969911', 'https://openalex.org/W2012595248', 'https://openalex.org/W1997759534', 'https://openalex.org/W1887764107'], 'abstract_inverted_index': {'Insights': [0], 'from': [1], 'cell': [2, 60, 97, 114, 171], 'cycle': [3, 172], 'research': [4], 'have': [5, 102], 'led': [6], 'to': [7, 16, 81, 152, 207], 'the': [8, 33, 36, 43, 119, 166, 201, 209], 'hypothesis': [9], 'that': [10, 35, 76], 'tumors': [11, 39], 'may': [12], 'be': [13], 'selectively': [14], 'sensitized': [15], 'DNA-damaging': [17, 146, 186, 197], 'agents': [18, 147], 'resulting': [19, 48], 'in': [20, 42, 49, 79, 130, 138, 141, 143, 155, 165, 183, 191, 222], 'improved': [21], 'antitumor': [22, 177], 'activity': [23], 'and': [24, 53, 59, 64, 94, 113, 140, 148, 215, 217], 'a': [25, 73, 103, 124, 223], 'wider': [26], 'therapeutic': [27], 'margin.': [28], 'The': [29, 62], 'theory': [30], 'relies': [31], 'on': [32, 51], 'observation': [34], 'majority': [37], 'of': [38, 86, 122, 161, 168, 176, 203, 211, 225], 'are': [40, 67], 'deficient': [41], 'G1-DNA': [44], 'damage': [45], 'checkpoint': [46, 70, 87, 106, 127, 162, 204], 'pathway': [47, 108], 'reliance': [50], 'S': [52, 63], 'G2': [54, 65], 'checkpoints': [55, 66], 'for': [56, 110], 'DNA': [57, 82, 92, 111, 169], 'repair': [58, 93, 112], 'survival.': [61, 115], 'regulated': [68], 'by': [69], 'kinase': [71, 75, 88, 128, 163, 205], '1,': [72], 'serine/threonine': [74], 'is': [77, 181], 'activated': [78], 'response': [80, 154, 220], 'damage;': [83], 'thus,': [84], 'inhibition': [85, 160], '1': [89], 'signaling': [90, 107], 'impairs': [91], 'increases': [95], 'tumor': [96], 'death.': [98], 'Normal': [99], 'tissues,': [100], 'however,': [101], 'functioning': [104], 'G1': [105], 'allowing': [109], 'Here,': [116], 'we': [117], 'describe': [118], 'preclinical': [120], 'profile': [121], 'AZD7762,': [123], 'potent': [125], 'ATP-competitive': [126], 'inhibitor': [129], 'clinical': [131], 'trials.': [132], 'AZD7762': [133, 180], 'has': [134, 149, 188], 'been': [135, 150, 189], 'profiled': [136], 'extensively': [137], 'vitro': [139], 'vivo': [142], 'combination': [144, 184], 'with': [145, 185, 195], 'shown': [151], 'potentiate': [153], 'several': [156, 196], 'different': [157], 'settings': [158], 'where': [159], 'results': [164], 'abrogation': [167], 'damage-induced': [170], 'arrest.': [173], 'Dose-dependent': [174], 'potentiation': [175], 'activity,': [178], 'when': [179], 'administered': [182], 'agents,': [187, 198], 'observed': [190], 'multiple': [192], 'xenograft': [193], 'models': [194], 'further': [199], 'supporting': [200], 'potential': [202], 'inhibitors': [206], 'enhance': [208], 'efficacy': [210], 'both': [212], 'conventional': [213], 'chemotherapy': [214], 'radiotherapy': [216], 'increase': [218], 'patient': [219], 'rates': [221], 'variety': [224], 'settings.': [226]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2162730779', 'counts_by_year': [{'year': 2024, 'cited_by_count': 13}, {'year': 2023, 'cited_by_count': 15}, {'year': 2022, 'cited_by_count': 20}, {'year': 2021, 'cited_by_count': 20}, {'year': 2020, 'cited_by_count': 16}, {'year': 2019, 'cited_by_count': 18}, {'year': 2018, 'cited_by_count': 23}, {'year': 2017, 'cited_by_count': 28}, {'year': 2016, 'cited_by_count': 26}, {'year': 2015, 'cited_by_count': 23}, {'year': 2014, 'cited_by_count': 24}, {'year': 2013, 'cited_by_count': 36}, {'year': 2012, 'cited_by_count': 34}], 'updated_date': '2024-12-19T15:05:10.428315', 'created_date': '2016-06-24'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
